BCEL
Atreca, Inc.
NASDAQHealthcareBiotechnologyUS
Company Profile
CEO
John A. Orwin
IPO Date
2019-06-20
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Atreca, Inc.
CEO
John A. Orwin
IPO Date
2019-06-20
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 7,061 |
| $0.37 |
| 3 Apr 2024 | Serafini Tito | director | S-Sale | Disposed | 20,788 | $0.07 |
| 3 Apr 2024 | Serafini Tito | director | S-Sale | Disposed | 8,393 | $0.37 |
| 3 Apr 2024 | Orwin John A | director, officer: PRESIDENT & CEO | S-Sale | Disposed | 22,951 | $0.37 |
| 23 Oct 2023 | BAKER BROS. ADVISORS LP | — | S-Sale | Disposed | 251,902 | $0.40 |
| 23 Oct 2023 | BAKER BROS. ADVISORS LP | — | S-Sale | Disposed | 22,837 | $0.40 |
| 4 Aug 2023 | Courtney Phillips | General Counsel & Secretary | S-Sale | Disposed | 4,076 | $0.95 |
| 4 Aug 2023 | CROSS HERB | Chief Financial Officer | S-Sale | Disposed | 5,487 | $0.95 |
| 4 Aug 2023 | Serafini Tito | director, officer: Chief Strategy Officer | S-Sale | Disposed | 5,487 | $0.95 |